Targeting Hepatitis C Vi Rus-Induced Hepatocellular Carcinoma with Precision Medicine-Tailored Oncolytic Measles Vi Rus(2/3)

Project: A - Government Institutionb - National Science and Technology Council

Project Details

StatusFinished
Effective start/end date8/1/197/31/20

Keywords

  • Hepatocellular carcinoma (HCC)
  • hepatitis C virus (HCV)
  • oncolytic virotherapy
  • measles virus (MV)
  • innate immunity
  • scFv diagnostics
  • precision medicine